Home » Newsletters » BioWorld Science

BioWorld Science

April 15, 2016

View Archived Issues

Phase II results demonstrate safety and efficacy of new drug for Wilson's disease

Oyi-based therapeutic HIV vaccine reduces the HIV RNA rebound median following cART interruption

TGI and Quark enter discovery and development collaboration

Zavante starts ZEUS trial for ZTI-01 in cUTI patients

KU Leuven and Ortho-McNeil-Janssen Pharmaceuticals patent dengue viral replication inhibitors

Oncolytics reports results on Reolysin phase II study

Akari and XL-protein to develop longer-acting version of Coversin

Synta Pharmaceuticals and Madrigal Pharmaceuticals announce merger agreement

RespiVert and Topivert Pharma disclose MAPK14, Src and Syk inhibitors

Redx Pharma develops IDO1 and/or TDO2 inhibitors

XuanZhu Pharma describes ALK and MCF3 inhibitors

Merrimack and Leica partner to develop companion diagnostic assays

PI3K inhibitors revealed in XuanZhu Pharma patent

Presage extends alliance with Takeda to provide access to CIVO platform

Burzynski Research Institute initiates phase II trial in diffuse intrinsic brainstem glioma

GeoVax receives SBIR grant for clade B HIV vaccine

TGen announces two new combination trials in pancreatic cancer

FDA acepts sBLA for Opdivo in patients with classical Hodgkin lymphoma

PsiOxus and Parker Institute collaborate on T-sign cancer platform

USAID launches Combating Zika and Future Threats: A Grand Challenge for Development

Phase I/IIa study investigates topically applied bisphosphocin Nu-3 for diabetic ulcers

FBRI and Meiji Seika collaborate on autoimmune and cancer drug research

Promising HCV T-cell vaccine HCV-003 to advance to phase II trials

Novel mutation in USMG5 gene may cause Leigh syndrome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...